Harvard Bioscience, Inc. (HBIO)
USD 0.4
(2.44%)
USD 0.4
(2.44%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 64.29 Million USD | -12.1% |
| 2022 | 73.14 Million USD | -7.35% |
| 2021 | 78.94 Million USD | -0.79% |
| 2020 | 79.57 Million USD | -4.33% |
| 2019 | 83.17 Million USD | -3.16% |
| 2018 | 85.88 Million USD | 201.85% |
| 2017 | 28.45 Million USD | -20.0% |
| 2016 | 35.56 Million USD | -16.54% |
| 2015 | 42.61 Million USD | 5.37% |
| 2014 | 40.44 Million USD | -1.29% |
| 2013 | 40.97 Million USD | 39.98% |
| 2012 | 29.27 Million USD | -5.99% |
| 2011 | 31.13 Million USD | -9.88% |
| 2010 | 34.54 Million USD | 8.05% |
| 2009 | 31.97 Million USD | 119.71% |
| 2008 | 14.55 Million USD | -41.12% |
| 2007 | 24.71 Million USD | 15.79% |
| 2006 | 21.34 Million USD | -9.63% |
| 2005 | 23.61 Million USD | -33.51% |
| 2004 | 35.52 Million USD | 20.21% |
| 2003 | 29.55 Million USD | 53.89% |
| 2002 | 19.2 Million USD | 23.49% |
| 2001 | 15.54 Million USD | 140.2% |
| 2000 | 6.47 Million USD | -48.73% |
| 1999 | 12.62 Million USD | 93.0% |
| 1998 | 6.54 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 64.34 Million USD | 0.09% |
| 2024 Q2 | 61.66 Million USD | -4.17% |
| 2023 Q2 | 67.51 Million USD | -5.23% |
| 2023 Q3 | 65.44 Million USD | -3.05% |
| 2023 Q4 | 64.29 Million USD | -1.77% |
| 2023 Q1 | 71.23 Million USD | -2.6% |
| 2023 FY | 64.29 Million USD | -12.1% |
| 2022 Q4 | 73.14 Million USD | -2.52% |
| 2022 FY | 73.14 Million USD | -7.35% |
| 2022 Q1 | 81.66 Million USD | 3.45% |
| 2022 Q2 | 77.76 Million USD | -4.78% |
| 2022 Q3 | 75.03 Million USD | -3.52% |
| 2021 Q3 | 76.98 Million USD | 2.28% |
| 2021 FY | 78.94 Million USD | -0.79% |
| 2021 Q1 | 74.13 Million USD | -6.84% |
| 2021 Q2 | 75.27 Million USD | 1.53% |
| 2021 Q4 | 78.94 Million USD | 2.54% |
| 2020 Q1 | 80.25 Million USD | -3.52% |
| 2020 Q2 | 74.61 Million USD | -7.02% |
| 2020 Q3 | 72.44 Million USD | -2.91% |
| 2020 Q4 | 79.57 Million USD | 9.84% |
| 2020 FY | 79.57 Million USD | -4.33% |
| 2019 FY | 83.17 Million USD | -3.16% |
| 2019 Q2 | 85.9 Million USD | -5.58% |
| 2019 Q1 | 90.98 Million USD | 5.94% |
| 2019 Q4 | 83.17 Million USD | -2.92% |
| 2019 Q3 | 85.67 Million USD | -0.27% |
| 2018 Q1 | 91.65 Million USD | 222.11% |
| 2018 FY | 85.88 Million USD | 201.85% |
| 2018 Q4 | 85.88 Million USD | 2.15% |
| 2018 Q3 | 84.08 Million USD | -4.49% |
| 2018 Q2 | 88.03 Million USD | -3.94% |
| 2017 FY | 28.45 Million USD | -20.0% |
| 2017 Q3 | 33.77 Million USD | 0.37% |
| 2017 Q2 | 33.64 Million USD | -2.98% |
| 2017 Q1 | 34.68 Million USD | -2.5% |
| 2017 Q4 | 28.45 Million USD | -15.75% |
| 2016 Q1 | 39.68 Million USD | -6.88% |
| 2016 FY | 35.56 Million USD | -16.54% |
| 2016 Q3 | 36.28 Million USD | -3.04% |
| 2016 Q2 | 37.42 Million USD | -5.7% |
| 2016 Q4 | 35.56 Million USD | -1.97% |
| 2015 Q3 | 39.26 Million USD | -10.27% |
| 2015 Q1 | 43.61 Million USD | 7.84% |
| 2015 FY | 42.61 Million USD | 5.37% |
| 2015 Q2 | 43.76 Million USD | 0.33% |
| 2015 Q4 | 42.61 Million USD | 8.53% |
| 2014 Q3 | 39.35 Million USD | -0.33% |
| 2014 Q2 | 39.48 Million USD | 0.95% |
| 2014 Q4 | 40.44 Million USD | 2.79% |
| 2014 Q1 | 39.1 Million USD | -4.55% |
| 2014 FY | 40.44 Million USD | -1.29% |
| 2013 FY | 40.97 Million USD | 39.98% |
| 2013 Q4 | 40.97 Million USD | 1.17% |
| 2013 Q3 | 40.5 Million USD | -0.42% |
| 2013 Q2 | 40.67 Million USD | 30.97% |
| 2013 Q1 | 31.05 Million USD | 6.09% |
| 2012 Q2 | 31.51 Million USD | -5.64% |
| 2012 Q3 | 30.21 Million USD | -4.12% |
| 2012 Q1 | 33.39 Million USD | 7.27% |
| 2012 Q4 | 29.27 Million USD | -3.13% |
| 2012 FY | 29.27 Million USD | -5.99% |
| 2011 FY | 31.13 Million USD | -9.88% |
| 2011 Q4 | 31.13 Million USD | 0.46% |
| 2011 Q3 | 30.99 Million USD | -3.76% |
| 2011 Q2 | 32.2 Million USD | -3.52% |
| 2011 Q1 | 33.37 Million USD | -3.39% |
| 2010 Q1 | 30.06 Million USD | -5.96% |
| 2010 Q2 | 27.41 Million USD | -8.82% |
| 2010 Q3 | 31.91 Million USD | 16.39% |
| 2010 FY | 34.54 Million USD | 8.05% |
| 2010 Q4 | 34.54 Million USD | 8.26% |
| 2009 Q3 | 34.59 Million USD | 173.72% |
| 2009 Q1 | 13.22 Million USD | -9.13% |
| 2009 FY | 31.97 Million USD | 119.71% |
| 2009 Q4 | 31.97 Million USD | -7.58% |
| 2009 Q2 | 12.63 Million USD | -4.43% |
| 2008 Q3 | 14.48 Million USD | -18.89% |
| 2008 Q1 | 17.93 Million USD | -27.43% |
| 2008 FY | 14.55 Million USD | -41.12% |
| 2008 Q4 | 14.55 Million USD | 0.46% |
| 2008 Q2 | 17.86 Million USD | -0.42% |
| 2007 FY | 24.71 Million USD | 15.79% |
| 2007 Q4 | 24.71 Million USD | 17.7% |
| 2007 Q3 | 21 Million USD | 18.89% |
| 2007 Q2 | 17.66 Million USD | -4.37% |
| 2007 Q1 | 18.47 Million USD | -13.46% |
| 2006 Q4 | 21.34 Million USD | 17.52% |
| 2006 FY | 21.34 Million USD | -9.63% |
| 2006 Q3 | 18.16 Million USD | -12.38% |
| 2006 Q2 | 20.73 Million USD | -6.38% |
| 2006 Q1 | 22.14 Million USD | -6.25% |
| 2005 Q4 | 23.61 Million USD | -26.74% |
| 2005 Q2 | 33.23 Million USD | 3.76% |
| 2005 Q3 | 32.24 Million USD | -3.01% |
| 2005 FY | 23.61 Million USD | -33.51% |
| 2005 Q1 | 32.03 Million USD | -9.82% |
| 2004 FY | 35.52 Million USD | 20.21% |
| 2004 Q4 | 35.52 Million USD | 7.13% |
| 2004 Q3 | 33.15 Million USD | -1.43% |
| 2004 Q1 | 36.3 Million USD | 22.85% |
| 2004 Q2 | 33.64 Million USD | -7.33% |
| 2003 Q3 | 25.59 Million USD | 2.56% |
| 2003 FY | 29.55 Million USD | 53.89% |
| 2003 Q1 | 26.53 Million USD | 38.2% |
| 2003 Q2 | 24.96 Million USD | -5.94% |
| 2003 Q4 | 29.55 Million USD | 15.44% |
| 2002 Q1 | 15.12 Million USD | -2.75% |
| 2002 FY | 19.2 Million USD | 23.49% |
| 2002 Q2 | 12.05 Million USD | -20.27% |
| 2002 Q4 | 19.2 Million USD | 50.68% |
| 2002 Q3 | 12.74 Million USD | 5.7% |
| 2001 FY | 15.54 Million USD | 140.2% |
| 2001 Q2 | 8.22 Million USD | 74.78% |
| 2001 Q3 | 7.82 Million USD | -4.79% |
| 2001 Q1 | 4.7 Million USD | -27.35% |
| 2001 Q4 | 15.54 Million USD | 98.7% |
| 2000 FY | 6.47 Million USD | -48.73% |
| 2000 Q4 | 6.47 Million USD | 0.0% |
| 1999 FY | 12.62 Million USD | 93.0% |
| 1998 FY | 6.54 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 126.59 Million USD | 49.216% |
| AngioDynamics, Inc. | 112.08 Million USD | 42.64% |
| AtriCure, Inc. | 147.76 Million USD | 56.49% |
| Avinger, Inc. | 19.97 Million USD | -221.911% |
| Azenta, Inc. | 351.22 Million USD | 81.695% |
| BioLife Solutions, Inc. | 75.05 Million USD | 14.336% |
| The Cooper Companies, Inc. | 4.1 Billion USD | 98.435% |
| Daxor Corporation | 858.75 Thousand USD | -7386.626% |
| Ekso Bionics Holdings, Inc. | 16.31 Million USD | -294.139% |
| Femasys Inc. | 9.4 Million USD | -583.722% |
| GlucoTrack, Inc. | 1.7 Million USD | -3664.169% |
| Hologic, Inc. | 4.02 Billion USD | 98.403% |
| ICU Medical, Inc. | 2.25 Billion USD | 97.149% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | 96.855% |
| KORU Medical Systems, Inc. | 8.1 Million USD | -693.023% |
| LeMaitre Vascular, Inc. | 48.87 Million USD | -31.536% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -9642.157% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -9642.157% |
| Masimo Corporation | 1.67 Billion USD | 96.166% |
| Microbot Medical Inc. | 3.82 Million USD | -1580.397% |
| Meihua International Medical Technologies Co., Ltd. | 25.07 Million USD | -156.374% |
| Merit Medical Systems, Inc. | 1.12 Billion USD | 94.276% |
| Nephros, Inc. | 3.5 Million USD | -1735.341% |
| NovoCure Limited | 783.63 Million USD | 91.796% |
| NEXGEL, Inc. | 4.78 Million USD | -1242.493% |
| NEXGEL, Inc. | 4.78 Million USD | -1242.493% |
| Singular Genomics Systems, Inc. | 86.46 Million USD | 25.64% |
| OraSure Technologies, Inc. | 52.17 Million USD | -23.226% |
| Pro-Dex, Inc. | 23.34 Million USD | -175.423% |
| Pulse Biosciences, Inc. | 16.44 Million USD | -290.975% |
| Predictive Oncology Inc. | 6.14 Million USD | -946.169% |
| Precision Optics Corporation, Inc. | 6.84 Million USD | -839.284% |
| QuidelOrtho Corporation | 3.55 Billion USD | 98.193% |
| Repligen Corporation | 853.2 Million USD | 92.465% |
| Sanara MedTech Inc. | 29.28 Million USD | -119.553% |
| STAAR Surgical Company | 102.73 Million USD | 37.421% |
| Sharps Technology, Inc. | 3.85 Million USD | -1567.764% |
| Utah Medical Products, Inc. | 7.14 Million USD | -799.818% |
| DENTSPLY SIRONA Inc. | 4.07 Billion USD | 98.423% |
| Jin Medical International Ltd. | 8.92 Million USD | -620.411% |